Ann Lab Med.
2019 Jan;39(1):113-113. 10.3343/alm.2019.39.1.113.
Erratum: Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea
- KMID: 2420283
- DOI: http://doi.org/10.3343/alm.2019.39.1.113
Abstract
- This erratum is being published to correct the company errors.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea
- Concurrent, Prolonged Use of Bedaquiline and Delamanid for Multidrug-Resistant Tuberculosis
- Shorter Oral Regimen for Multidrug Resistant Tuberculosis in South Korea
- Medical Treatment of Pulmonary Multidrug-Resistant Tuberculosis
- Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
